Establishment Labs (ESTA) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Establishment Labs (ESTA) has outperformed Pacific Biosciences of California (PACB) over the past year, gaining 53.7% versus a gain of 52.3%. Over five years, ESTA leads with a -19.9% price change compared with -90.4% for PACB. Establishment Labs is the larger company by market cap ($1.84 billion vs $724.2 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESTA | PACB |
|---|---|---|
| Share price | $61.67 | $2.33 |
| Market cap | $1.84B | $724.24M |
| 1-day change | +1.75% | +1.30% |
| YTD return | -15.38% | +24.60% |
| 1-year return | +53.71% | +52.29% |
| 5-year return | -19.91% | -90.45% |
| EPS (TTM) | $-1.30 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $211.08M | — |
| Revenue growth (YoY) | +27.14% | — |
| Net income (latest FY) | $-51.06M | — |
| Gross margin | 69.32% | — |
| Operating margin | -18.48% | — |
| Net margin | -24.19% | — |
| 52-week high | $97.59 | $3.44 |
| 52-week low | $38.38 | $1.07 |
| Distance from 52-week high | -36.81% | -32.27% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +66.11% | +3.00% |
| Average volume | 427.13K | 10.39M |
| Shares outstanding | 29.80M | 310.83M |
| Employees | 1,004 | 485 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Establishment Labs is about 2.5 times larger than Pacific Biosciences of California by market value ($1.84B vs $724.24M).
- The two companies sit in different sectors: Establishment Labs in Health Care and Pacific Biosciences of California in Industrials.
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
ESTA vs PACB FAQ
Which is bigger, Establishment Labs or Pacific Biosciences of California?
Establishment Labs (ESTA) is larger, with a market capitalization of $1.84B compared with $724.24M for Pacific Biosciences of California (PACB).
Which stock has performed better over the past year, ESTA or PACB?
ESTA returned +53.71% over the past 12 months, compared with +52.29% for PACB (price return, excluding dividends). Past performance does not predict future results.
Are Establishment Labs and Pacific Biosciences of California in the same industry?
No. Establishment Labs is in the Health Care sector, while Pacific Biosciences of California is in Industrials.